These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11517183)

  • 1. Ovarian granulosa cell tumors express a functional membrane receptor for anti-Müllerian hormone in transgenic mice.
    Dutertre M; Gouédard L; Xavier F; Long WQ; di Clemente N; Picard JY; Rey R
    Endocrinology; 2001 Sep; 142(9):4040-6. PubMed ID: 11517183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the anti-müllerian hormone served as a marker for granulosa cell tumor of ovary].
    Long W; Wang W; Rey R
    Zhonghua Fu Chan Ke Za Zhi; 2000 Jun; 35(6):356-8. PubMed ID: 11776178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth.
    Baarends WM; Uilenbroek JT; Kramer P; Hoogerbrugge JW; van Leeuwen EC; Themmen AP; Grootegoed JA
    Endocrinology; 1995 Nov; 136(11):4951-62. PubMed ID: 7588229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
    Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
    Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor.
    Gouédard L; Chen YG; Thevenet L; Racine C; Borie S; Lamarre I; Josso N; Massague J; di Clemente N
    J Biol Chem; 2000 Sep; 275(36):27973-8. PubMed ID: 10854429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo.
    Pieretti-Vanmarcke R; Donahoe PK; Szotek P; Manganaro T; Lorenzen MK; Lorenzen J; Connolly DC; Halpern EF; MacLaughlin DT
    Clin Cancer Res; 2006 Mar; 12(5):1593-8. PubMed ID: 16533786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Müllerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumor cells by activating apoptosis.
    Anttonen M; Färkkilä A; Tauriala H; Kauppinen M; Maclaughlin DT; Unkila-Kallio L; Bützow R; Heikinheimo M
    Lab Invest; 2011 Nov; 91(11):1605-14. PubMed ID: 21808236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Müllerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors.
    Rey R; Sabourin JC; Venara M; Long WQ; Jaubert F; Zeller WP; Duvillard P; Chemes H; Bidart JM
    Hum Pathol; 2000 Oct; 31(10):1202-8. PubMed ID: 11070112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of anti-Müllerian hormone (AMH) in equine granulosa-cell tumors and in normal equine ovaries.
    Ball BA; Conley AJ; MacLaughlin DT; Grundy SA; Sabeur K; Liu IK
    Theriogenology; 2008 Oct; 70(6):968-77. PubMed ID: 18599114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High GATA-4 expression associates with aggressive behavior, whereas low anti-Müllerian hormone expression associates with growth potential of ovarian granulosa cell tumors.
    Anttonen M; Unkila-Kallio L; Leminen A; Butzow R; Heikinheimo M
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6529-35. PubMed ID: 16159935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.
    di Clemente N; Wilson C; Faure E; Boussin L; Carmillo P; Tizard R; Picard JY; Vigier B; Josso N; Cate R
    Mol Endocrinol; 1994 Aug; 8(8):1006-20. PubMed ID: 7997230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
    Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
    Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mouse Sertoli cell line expressing anti-Müllerian hormone and its type II receptor.
    Dutertre M; Rey R; Porteu A; Josso N; Picard JY
    Mol Cell Endocrinol; 1997 Dec; 136(1):57-65. PubMed ID: 9510068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of anti-Müllerian hormone (amh) and anti-Müllerian hormone receptor type II (amhrII) in the teleost medaka.
    Klüver N; Pfennig F; Pala I; Storch K; Schlieder M; Froschauer A; Gutzeit HO; Schartl M
    Dev Dyn; 2007 Jan; 236(1):271-81. PubMed ID: 17075875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-Müllerian hormone type II receptor: insights into the binding domains recognized by a monoclonal antibody and the natural ligand.
    Salhi I; Cambon-Roques S; Lamarre I; Laune D; Molina F; Pugnière M; Pourquier D; Gutowski M; Picard JY; Xavier F; Pèlegrin A; Navarro-Teulon I
    Biochem J; 2004 May; 379(Pt 3):785-93. PubMed ID: 14750901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological and clinical significance of anti-Müllerian hormone determination in blood serum of the mare.
    Almeida J; Ball BA; Conley AJ; Place NJ; Liu IK; Scholtz EL; Mathewson L; Stanley SD; Moeller BC
    Theriogenology; 2011 Nov; 76(8):1393-403. PubMed ID: 21798581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sertoli Cell-Specific Activation of Transforming Growth Factor Beta Receptor 1 Leads to Testicular Granulosa Cell Tumor Formation.
    Fang X; Nie L; Putluri S; Ni N; Bartholin L; Li Q
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High specificity of Müllerian-inhibiting substance signaling in vivo.
    Mishina Y; Whitworth DJ; Racine C; Behringer RR
    Endocrinology; 1999 May; 140(5):2084-8. PubMed ID: 10218958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal recessive segregation of a truncating mutation of anti-Müllerian type II receptor in a family affected by the persistent Müllerian duct syndrome contrasts with its dominant negative activity in vitro.
    Messika-Zeitoun L; Gouédard L; Belville C; Dutertre M; Lins L; Imbeaud S; Hughes IA; Picard JY; Josso N; di Clemente N
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4390-7. PubMed ID: 11549681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of ovarian function: the role of anti-Müllerian hormone.
    Durlinger AL; Visser JA; Themmen AP
    Reproduction; 2002 Nov; 124(5):601-9. PubMed ID: 12416998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.